Report copyright - Innovative Therapies for Retinal Disorders : Developing ... Corp... · Company & Investor Presentation –November, 2017. ... €113.4 m (Q3 FY17) o Listed on Euronext Brussels
Please pass captcha verification before submit form
Please pass captcha verification before submit form